1
|
Li JH, Trivedi V, Diz-Muñoz A. Understanding the interplay of membrane trafficking, cell surface mechanics, and stem cell differentiation. Semin Cell Dev Biol 2023; 133:123-134. [PMID: 35641408 PMCID: PMC9703995 DOI: 10.1016/j.semcdb.2022.05.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 04/08/2022] [Accepted: 05/14/2022] [Indexed: 01/17/2023]
Abstract
Stem cells can generate a diversity of cell types during development, regeneration and adult tissue homeostasis. Differentiation changes not only the cell fate in terms of gene expression but also the physical properties and functions of cells, e.g. the secretory activity, cell shape, or mechanics. Conversely, these activities and properties can also regulate differentiation itself. Membrane trafficking is known to modulate signal transduction and thus has the potential to control stem cell differentiation. On the other hand, membrane trafficking, particularly from and to the plasma membrane, depends on the mechanical properties of the cell surface such as tension within the plasma membrane or the cortex. Indeed, recent findings demonstrate that cell surface mechanics can also control cell fate. Here, we review the bidirectional relationships between these three fundamental cellular functions, i.e. membrane trafficking, cell surface mechanics, and stem cell differentiation. Furthermore, we discuss commonly used methods in each field and how combining them with new tools will enhance our understanding of their interplay. Understanding how membrane trafficking and cell surface mechanics can guide stem cell fate holds great potential as these concepts could be exploited for directed differentiation of stem cells for the fields of tissue engineering and regenerative medicine.
Collapse
Affiliation(s)
- Jia Hui Li
- Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Meyerhofstraße 1, Heidelberg 69117, Germany
| | - Vikas Trivedi
- EMBL, PRBB, Dr. Aiguader, 88, Barcelona 08003, Spain,Developmental Biology Unit, EMBL, Meyerhofstraße 1, Heidelberg 69117, Germany
| | - Alba Diz-Muñoz
- Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Meyerhofstraße 1, Heidelberg 69117, Germany.
| |
Collapse
|
2
|
Sanchez M, Hamel D, Bajon E, Duhamel F, Bhosle VK, Zhu T, Rivera JC, Dabouz R, Nadeau-Vallée M, Sitaras N, Tremblay DÉ, Omri S, Habelrih T, Rouget R, Hou X, Gobeil F, Joyal JS, Sapieha P, Mitchell G, Ribeiro-Da-Silva A, Mohammad Nezhady MA, Chemtob S. The Succinate Receptor SUCNR1 Resides at the Endoplasmic Reticulum and Relocates to the Plasma Membrane in Hypoxic Conditions. Cells 2022; 11:2185. [PMID: 35883628 PMCID: PMC9321536 DOI: 10.3390/cells11142185] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Revised: 07/08/2022] [Accepted: 07/09/2022] [Indexed: 12/24/2022] Open
Abstract
The GPCR SUCNR1/GPR91 exerts proangiogenesis upon stimulation with the Krebs cycle metabolite succinate. GPCR signaling depends on the surrounding environment and intracellular localization through location bias. Here, we show by microscopy and by cell fractionation that in neurons, SUCNR1 resides at the endoplasmic reticulum (ER), while being fully functional, as shown by calcium release and the induction of the expression of the proangiogenic gene for VEGFA. ER localization was found to depend upon N-glycosylation, particularly at position N8; the nonglycosylated mutant receptor localizes at the plasma membrane shuttled by RAB11. This SUCNR1 glycosylation is physiologically regulated, so that during hypoxic conditions, SUCNR1 is deglycosylated and relocates to the plasma membrane. Downstream signal transduction of SUCNR1 was found to activate the prostaglandin synthesis pathway through direct interaction with COX-2 at the ER; pharmacologic antagonism of the PGE2 EP4 receptor (localized at the nucleus) was found to prevent VEGFA expression. Concordantly, restoring the expression of SUCNR1 in the retina of SUCNR1-null mice renormalized vascularization; this effect is markedly diminished after transfection of the plasma membrane-localized SUCNR1 N8A mutant, emphasizing that ER localization of the succinate receptor is necessary for proper vascularization. These findings uncover an unprecedented physiologic process where GPCR resides at the ER for signaling function.
Collapse
Affiliation(s)
- Melanie Sanchez
- Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada; (M.S.); (V.K.B.); (R.D.); (R.R.); (A.R.-D.-S.)
| | - David Hamel
- Department of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada; (D.H.); (F.D.); (M.N.-V.); (N.S.); (D.-É.T.); (T.H.)
| | - Emmanuel Bajon
- Department of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada; (E.B.); (T.Z.); (X.H.); (J.-S.J.); (G.M.)
| | - François Duhamel
- Department of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada; (D.H.); (F.D.); (M.N.-V.); (N.S.); (D.-É.T.); (T.H.)
| | - Vikrant K. Bhosle
- Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada; (M.S.); (V.K.B.); (R.D.); (R.R.); (A.R.-D.-S.)
- Cell Biology Program, The Hospital for Sick Children Research Institute, Toronto, ON M5G 1X8, Canada
| | - Tang Zhu
- Department of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada; (E.B.); (T.Z.); (X.H.); (J.-S.J.); (G.M.)
| | - Jose Carlos Rivera
- Department of Ophthalmology, Research Center of Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC H1T 2M4, Canada; (J.C.R.); (S.O.); (P.S.)
| | - Rabah Dabouz
- Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada; (M.S.); (V.K.B.); (R.D.); (R.R.); (A.R.-D.-S.)
| | - Mathieu Nadeau-Vallée
- Department of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada; (D.H.); (F.D.); (M.N.-V.); (N.S.); (D.-É.T.); (T.H.)
| | - Nicholas Sitaras
- Department of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada; (D.H.); (F.D.); (M.N.-V.); (N.S.); (D.-É.T.); (T.H.)
| | - David-Étienne Tremblay
- Department of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada; (D.H.); (F.D.); (M.N.-V.); (N.S.); (D.-É.T.); (T.H.)
| | - Samy Omri
- Department of Ophthalmology, Research Center of Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC H1T 2M4, Canada; (J.C.R.); (S.O.); (P.S.)
| | - Tiffany Habelrih
- Department of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada; (D.H.); (F.D.); (M.N.-V.); (N.S.); (D.-É.T.); (T.H.)
| | - Raphael Rouget
- Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada; (M.S.); (V.K.B.); (R.D.); (R.R.); (A.R.-D.-S.)
| | - Xin Hou
- Department of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada; (E.B.); (T.Z.); (X.H.); (J.-S.J.); (G.M.)
| | - Fernand Gobeil
- Department of Pharmacology, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada;
| | - Jean-Sébastien Joyal
- Department of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada; (E.B.); (T.Z.); (X.H.); (J.-S.J.); (G.M.)
- Department of Ophthalmology, Research Center of Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC H1T 2M4, Canada; (J.C.R.); (S.O.); (P.S.)
| | - Przemyslaw Sapieha
- Department of Ophthalmology, Research Center of Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC H1T 2M4, Canada; (J.C.R.); (S.O.); (P.S.)
| | - Grant Mitchell
- Department of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada; (E.B.); (T.Z.); (X.H.); (J.-S.J.); (G.M.)
| | - Alfredo Ribeiro-Da-Silva
- Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada; (M.S.); (V.K.B.); (R.D.); (R.R.); (A.R.-D.-S.)
| | - Mohammad Ali Mohammad Nezhady
- Department of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada; (E.B.); (T.Z.); (X.H.); (J.-S.J.); (G.M.)
- Program of Molecular Biology, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada
- Research Center-CHU Ste-Justine, Departments of Pediatrics, Ophthalmology, and Pharmacology, Faculty of Medicine, Université de Montréal, 3175, Chemin Côte Ste-Catherine, Montréal, QC H3T 1C5, Canada
| | - Sylvain Chemtob
- Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada; (M.S.); (V.K.B.); (R.D.); (R.R.); (A.R.-D.-S.)
- Department of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada; (D.H.); (F.D.); (M.N.-V.); (N.S.); (D.-É.T.); (T.H.)
- Department of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada; (E.B.); (T.Z.); (X.H.); (J.-S.J.); (G.M.)
- Department of Ophthalmology, Research Center of Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC H1T 2M4, Canada; (J.C.R.); (S.O.); (P.S.)
- Research Center-CHU Ste-Justine, Departments of Pediatrics, Ophthalmology, and Pharmacology, Faculty of Medicine, Université de Montréal, 3175, Chemin Côte Ste-Catherine, Montréal, QC H3T 1C5, Canada
| |
Collapse
|
3
|
Dai S, Li N, Zhou M, Yuan Y, Yue D, Li T, Zhang X. LncRNA EBLN3P promotes the progression of osteosarcoma through modifying the miR-224-5p/Rab10 signaling axis. Sci Rep 2021; 11:1992. [PMID: 33479458 PMCID: PMC7820338 DOI: 10.1038/s41598-021-81641-6] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2020] [Accepted: 01/06/2021] [Indexed: 01/06/2023] Open
Abstract
The treatment of patients with advanced-stage osteosarcoma represents a major challenge, with very few treatments currently approved. Although accumulating evidence has demonstrated the importance of lncRNAs in osteosarcoma, the current knowledge on the functional roles and molecular mechanisms of lncRNA endogenous born avirus-like nucleoprotein (EBLN3P) is limited. At present, the expressions of EBLN3P and miR-224-5p in osteosarcoma tissues were quantified by reverse transcription-quantitative PCR assay, and the expression of Ras-related protein 10 (Rab10) in osteosarcoma tissues was quantified by immunohistochemistry and western-blotting. The bioinformatics prediction software ENCORI was used to predict the putative binding sites of EBLN3P, Rab10 and miR-224-5p. The regulatory role of EBLN3P or miR-224-5p on cell proliferation, migration and invasion ability were verified by Cell Counting Kit-8, wound healing and Transwell assays, respectively. The interaction among EBLN3P, miR-224-5p and Rab10 were testified by luciferase. The increased expression of EBLN3P and Rab10 and decreased expression of miR-224-5p were observed in osteosarcoma tissues and cell lines. Besides, the overexpression of EBLN3P or knockdown of miR-224-5p were revealed to promote the proliferation, migration and invasion of osteosarcoma cells. Bioinformatics analysis and luciferase assay revealed that EBLN3P could directly interacted with miR-224-5p to attenuate miR-224-5p binding to the Rab10 3'-untranslated region. Furthermore, the mechanistic investigations revealed activation of the miR-224-5p/Rab10 regulatory loop by knockdown of miR-372-3p or overexpression of Rab10, thereby confirming the in vitro role of EBLN3P in promoting osteosarcoma cell proliferation, migration and invasion. To the best of our knowledge, the present study is the first to demonstrate that EBLN3P may act as a competitive endogenous RNA to modulate Rab10 expression by competitive sponging to miR-224-5p, leading to the regulation of osteosarcoma progression, which indicates a possible new approach to osteosarcoma diagnosis and treatment.
Collapse
Affiliation(s)
- Shuhong Dai
- Department of Cardiac Intensive Care Unit, Zibo Central Hospital, Zibo, Shandong Province, China
| | - Ning Li
- Department of Combination of Chinese Traditional and Western Medicine, Zibo Central Hospital, Zibo, Shandong Province, China
| | - Ming Zhou
- Department of Orthopedic Surgery, Zibo Central Hospital, Zibo, Shandong Province, China
| | - Yue Yuan
- Experimental Center of Medical Biology, School of Basic Medical Sciences, Jilin University, Changchun, China
| | - Ding Yue
- Department of Pathogen Biology, The Key Laboratory of Zoonosis, Chinese Ministry of Education, College of Basic Medicine, Jilin University, Changchun, 130021, Jilin, China
| | - Tao Li
- Department of Orthopedic Surgery, Zibo Central Hospital, Zibo, Shandong Province, China.
- Center for Translational Medicine, Zibo Central Hospital, Zibo, Shandong Province, China.
| | - Xiaowei Zhang
- Department of Orthopedic Surgery, Zibo Central Hospital, Zibo, Shandong Province, China.
- Center for Translational Medicine, Zibo Central Hospital, Zibo, Shandong Province, China.
| |
Collapse
|
4
|
Prince E, Kroeger B, Gligorov D, Wilson C, Eaton S, Karch F, Brankatschk M, Maeda RK. Rab-mediated trafficking in the secondary cells of Drosophila male accessory glands and its role in fecundity. Traffic 2018; 20:137-151. [PMID: 30426623 PMCID: PMC6492190 DOI: 10.1111/tra.12622] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2018] [Revised: 11/01/2018] [Accepted: 11/06/2018] [Indexed: 12/16/2022]
Abstract
The male seminal fluid contains factors that affect female post‐mating behavior and physiology. In Drosophila, most of these factors are secreted by the two epithelial cell types that make up the male accessory gland: the main and secondary cells. Although secondary cells represent only ~4% of the cells of the accessory gland, their contribution to the male seminal fluid is essential for sustaining the female post‐mating response. To better understand the function of the secondary cells, we investigated their molecular organization, particularly with respect to the intracellular membrane transport machinery. We determined that large vacuole‐like structures found in the secondary cells are trafficking hubs labeled by Rab6, 7, 11 and 19. Furthermore, these organelles require Rab6 for their formation and many are essential in the process of creating the long‐term postmating behavior of females. In order to better serve the intracellular membrane and protein trafficking communities, we have created a searchable, online, open‐access imaging resource to display our complete findings regarding Rab localization in the accessory gland.
Collapse
Affiliation(s)
- Elodie Prince
- Department of Genetics and Evolution, Section of Biology, Sciences Faculty, University of Geneva, Geneva, Switzerland
| | - Benjamin Kroeger
- Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
| | - Dragan Gligorov
- Department of Genetics and Evolution, Section of Biology, Sciences Faculty, University of Geneva, Geneva, Switzerland
| | - Clive Wilson
- Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
| | - Suzanne Eaton
- Biotechnology Center of the TU Dresden, Dresden, Germany.,Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
| | - François Karch
- Department of Genetics and Evolution, Section of Biology, Sciences Faculty, University of Geneva, Geneva, Switzerland
| | - Marko Brankatschk
- Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
| | - Robert K Maeda
- Department of Genetics and Evolution, Section of Biology, Sciences Faculty, University of Geneva, Geneva, Switzerland
| |
Collapse
|